A specific, glycomimetic Langerin ligand for human Langerhans cell targeting
E.-C. Wamhoff, J. Schulze, L. Bellmann, G. Bachem, F. F. Fuchsberger, J. Rademacher, M. Hermann, B. Del Frari, R. van Dalen, D. Hartmann, N. van Sorge, O. Seitz, P. Stoitzner, C. Rademacher
The paper develops a glycomimetic Langerin ligand for targeting Langerhans cells, enabling efficient antigen and adjuvant delivery for cancer vaccines.
bioRxiv · Mar 31, 2018Immunology